What 2,500 Sequenced Genomes Say about Humanity’s Future
By Lizzie Wade,
Wired
| 09. 30. 2015
When the geneticist Gonçalo Abecasis stood up in front of a group of scientists in 2007 and proposed sequencing 1,000 genomes from people all over the world, he had no idea how he was going to pull it off. The Human Genome Project had published the first complete map of the human genome just four years earlier, and the technology remained exorbitantly expensive. “Imagine you’ve done ten of these,” Abecasis says today of the number of human genomes that had been sequenced at the time. “The first one cost $3 billion, and the other ones cost several million. And you say, ‘what if we set out to do a thousand?’”
The price wasn’t the only hurdle. “When we first started talking about doing these genome-wide comparisons between populations”—i.e., groups of people from different continents or with different ancestries—“there was a lot of tension,” remembers Abecasis, now at the University of Michigan. That’s because, frankly, “human population” sounds a lot like “race.”
Sequencing the human genome showed that humans are all much more alike than different; genome pioneer J. Craig Venter...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...